Atlas Trials

Evaluation of Plasma Sphingosine-1-Phosphate as A Diagnostic and Prognostic Biomarkers of Community-Acquired Pneumonia

Clinical trial NCT03473119 · UNKNOWN

Trial details

NCT number
NCT03473119
Sponsor
Taipei Medical University WanFang Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
PneumoniaChronic Obstructive Pulmonary DiseaseAsthma
Start date
2016-03-19
Primary completion
2021-03-19
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.